Lerzeparib

Details

Stereochemistry	ABSOLUTE
Molecular Formula	C21H20FN3O2
Molecular Weight	365.4008
Optical Activity	UNSPECIFIED
Defined Stereocenters	1 / 1
E/Z Centers	0
Charge	0

SHOW SMILES / InChI

Structure Search

SMILES

C[C@@]1(CCCN1)C2=CC=C(C=C2)C3=C4CONC(=O)C5=C4C(N3)=CC(F)=C5

InChI

InChIKey=FBKICCXLQKLXAZ-OAQYLSRUSA-N

InChI=1S/C21H20FN3O2/c1-21(7-2-8-23-21)13-5-3-12(4-6-13)19-16-11-27-25-20(26)15-9-14(22)10-17(24-19)18(15)16/h3-6,9-10,23-24H,2,7-8,11H2,1H3,(H,25,26)/t21-/m1/s1

HIDE SMILES / InChI

Molecular Formula	C21H20FN3O2
Molecular Weight	365.4008
Charge	0
Count

Stereochemistry	ABSOLUTE
Additional Stereochemistry	No
Defined Stereocenters	1 / 1
E/Z Centers	0
Optical Activity	UNSPECIFIED

Approval Year

Substance Class	Chemical Created by `admin` on `Sat Dec 16 20:17:52 GMT 2023` Edited by `admin` on `Sat Dec 16 20:17:52 GMT 2023`
Record UNII	FA3YB8W7X9
Record Status	`Validated (UNII)`
Record Version

Download

Name

Type

Language

Lerzeparib

Official Name

English

lerzeparib [INN]

Common Name

English

8-Fluoro-1,3-dihydro-2-[4-[(2R)-2-methyl-2-pyrrolidinyl]phenyl]pyrrolo[4,3,2-ef][3,2]benzoxazepin-6(5H)-one

Systematic Name

English

Pyrrolo[4,3,2-ef][3,2]benzoxazepin-6(5H)-one, 8-fluoro-1,3-dihydro-2-[4-[(2R)-2-methyl-2-pyrrolidinyl]phenyl]-

Systematic Name

English

Code System Code Type Description

FDA UNII

FA3YB8W7X9

Created by admin on Sat Dec 16 20:17:52 GMT 2023 , Edited by admin on Sat Dec 16 20:17:52 GMT 2023

PRIMARY

INN

12699

Created by admin on Sat Dec 16 20:17:52 GMT 2023 , Edited by admin on Sat Dec 16 20:17:52 GMT 2023

PRIMARY

PUBCHEM

155033943

Created by admin on Sat Dec 16 20:17:52 GMT 2023 , Edited by admin on Sat Dec 16 20:17:52 GMT 2023

PRIMARY

CAS

2459693-01-5

Created by admin on Sat Dec 16 20:17:52 GMT 2023 , Edited by admin on Sat Dec 16 20:17:52 GMT 2023

PRIMARY

Related Record Type Details


					FA3YB8W7X9

Lerzeparib

ACTIVE MOIETY

Comments:

(PARP) inhibiton

Amount: